Some people think AZN’s $15.2B takeover of MEDI in 2007 was the worst acquisition in biotech history (#msg-19020387, #msg-19020497). Regardless, AZN is probably in the worst shape of any Big Pharma. In Feb 2012, AZN announced a cut of 7,300 jobs (#msg-71620282); the new cuts at MedImmune are in addition to that number.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.